您的位置: 首页 > 2023年6月 第54卷 第6期 > 文字全文
2023年7月 第38卷 第7期11
目录

藏族女性子宫癌肉瘤1例并文献复习

A case of Tibetan female uterine carcinosarcoma and literature review

来源期刊: 广州医药 | 56-60 发布时间:2023-07-27 收稿时间:2025/11/13 18:33:33 阅读量:17
作者:
关键词:
子宫癌肉瘤临床病理特征治疗
uterine carcinosarcomasclinicopathological featurestreatment
DOI:
10.3969/j.issn.1000-8535.2023.06.010
收稿时间:
2022-08-17 
修订日期:
 
接收日期:
 
引用总数:
1  
目的 分析子宫癌肉瘤的临床诊疗过程及其特征,以期提高对该病的认识。方法 回顾性分析我院收治的1例藏族女性子宫癌肉瘤患者的临床资料。并检索中国万方、中华医学期刊、PubMed等数据库,对相关文献进行系统性分析,归纳其临床、病理特点。结果 本例患者术后一般情况良好,切口痊愈出院,电话随访了解到患者术后9月均未按期进行复查,亦未行术后辅助治疗,无法获得辅助治疗和随访复诊的情况。结论 子宫癌肉瘤在临床上较为少见,无特异性临床表现,确诊依靠病理,病理上有特殊性,含有癌和肉瘤两种组织成分,治疗上参考子宫内膜癌的高危特殊组织类型处理,但缺少有效的治疗手段,需要采用各种综合治疗,预后较差。
Objective To analyze the clinical diagnosis and treatment of uterine carcinosarcoma and its characteristics,in order to improve the understanding of the disease.Methods The clinical data of a Tibetan woman with uterine carcinosarcoma treated in our hospital was analyzed retrospectively.The databases of China Wanfang,Chinese Medical Journal and PubMed were searched,and the relevant literatures were systematically analyzed to summarize the clinical and pathological characteristics.Results This patient was generally in good condition after operation.The incision was healed and she was discharged.The telephone follow-up found that the patient did not receive re-examination as scheduled in 9 months after the operation,and did not receive postoperative adjuvant treatment.The follow-up situation was unable to obtain.Conclusions Uterine carcinosarcoma is relatively rare in clinic and has no specific clinical manifestations.The diagnosis depends on pathology.It has particularity in pathology and contains two kinds of tissue components:cancer and sarcoma.Treatment refers to high-risk special tissue types of endometrial cancer,but there is a lack of effective treatment means,a variety of comprehensive treatment is needed,and the prognosis is poor.
1、 李爱华,张师前,孙阳,等.子宫癌肉瘤诊治中国专家共识(2020年版)[J].中国癌症防治杂志,2020,12(6):599-605. 李爱华,张师前,孙阳,等.子宫癌肉瘤诊治中国专家共识(2020年版)[J].中国癌症防治杂志,2020,12(6):599-605.
2、 CANTRELL L A,HAVRILESKY L,MOORE D T,et al.A multi-institutional cohort study of adjuvant therapy in stage Ⅰ-Ⅱ uterine carcinosarcoma[J].Gynecol Oncol,2012,127(1):22-26. CANTRELL L A,HAVRILESKY L,MOORE D T,et al.A multi-institutional cohort study of adjuvant therapy in stage Ⅰ-Ⅱ uterine carcinosarcoma[J].Gynecol Oncol,2012,127(1):22-26.
3、 孙建衡,蔡树模,高永良.妇科肿瘤学[M].北京:北京大学医学出版社,2011:783-797. 孙建衡,蔡树模,高永良.妇科肿瘤学[M].北京:北京大学医学出版社,2011:783-797.
4、 谢玲玲,林荣春,林仲秋.2021 NCCN子宫肿瘤临床实践指南(第1版)解读[J].中国实用妇科与产科杂志,2021,37(1):75-81. 谢玲玲,林荣春,林仲秋.2021 NCCN子宫肿瘤临床实践指南(第1版)解读[J].中国实用妇科与产科杂志,2021,37(1):75-81.
5、 吴小华,刘继红,吴令英,等.中国抗癌协会妇科肿瘤专业委员会.子宫内膜癌诊断与治疗指南(2021年版)[J].中国癌症杂志,2021,31(6):501-512. 吴小华,刘继红,吴令英,等.中国抗癌协会妇科肿瘤专业委员会.子宫内膜癌诊断与治疗指南(2021年版)[J].中国癌症杂志,2021,31(6):501-512.
6、 邓波儿,孔为民.子宫癌肉瘤的诊治进展[J].医学综述,2017,23(22):4438-4442. 邓波儿,孔为民.子宫癌肉瘤的诊治进展[J].医学综述,2017,23(22):4438-4442.
7、 MENCZER J.Review of recommended treatment of uterine carcinosarcoma[J].Curr Treat Options Oncol,2015,16(11):53. MENCZER J.Review of recommended treatment of uterine carcinosarcoma[J].Curr Treat Options Oncol,2015,16(11):53.
8、 KANTHAN R,SENGER J L.Uterine carcinosarcomas(malignant mixed mullerian tumours):A review with special emphasis on the controversies in management[J].Obster Gynecol Int,2011(2011):470795. KANTHAN R,SENGER J L.Uterine carcinosarcomas(malignant mixed mullerian tumours):A review with special emphasis on the controversies in management[J].Obster Gynecol Int,2011(2011):470795.
9、 黄鹤,刘继红.认识女性生殖道癌肉瘤[J].中国实用妇科与产科杂志,2017,33(4):338-342. 黄鹤,刘继红.认识女性生殖道癌肉瘤[J].中国实用妇科与产科杂志,2017,33(4):338-342.
10、 谢幸,孔北华,段涛,等.妇产科学[M].第九版.北京:人民卫生出版社,2018:307-308. 谢幸,孔北华,段涛,等.妇产科学[M].第九版.北京:人民卫生出版社,2018:307-308.
11、 孙建衡,盛修贵,白萍.妇科肿瘤学[M].第二版,北京:北京大学医学出版社,2019:846-856. 孙建衡,盛修贵,白萍.妇科肿瘤学[M].第二版,北京:北京大学医学出版社,2019:846-856.
12、 李灿,李慧,程静新.绝经后子宫内膜增厚与子宫内膜病变的相关性研究[J].实用妇产科杂志,2021,37(1):62-66. 李灿,李慧,程静新.绝经后子宫内膜增厚与子宫内膜病变的相关性研究[J].实用妇产科杂志,2021,37(1):62-66.
13、 张英丽,朱滔,张平.子宫癌肉瘤分子病理特征及临床治疗进展[J].实用癌症杂志,2019,34(8):1390-1392. 张英丽,朱滔,张平.子宫癌肉瘤分子病理特征及临床治疗进展[J].实用癌症杂志,2019,34(8):1390-1392.
14、 CANTRELL L A,BLANK S V,DUSKA L R.Uterine carcinosarcoma:A review of the literature[J].Gynecol Oncol,2015,137(3):581-588. CANTRELL L A,BLANK S V,DUSKA L R.Uterine carcinosarcoma:A review of the literature[J].Gynecol Oncol,2015,137(3):581-588.
15、 李小毛,欧阳婧.子宫癌肉瘤106例临床分析[J].中国实用妇科与产科杂志,2015,12(10):927-931. 李小毛,欧阳婧.子宫癌肉瘤106例临床分析[J].中国实用妇科与产科杂志,2015,12(10):927-931.
1、罗亮,史成良,王敏,等.恶性中胚叶混合瘤临床病理特征分析[J].广州医药,2025,56(02):160-165.DOI:10.20223/j.cnki.1000-8535.2025.02.003. 罗亮,史成良,王敏,等.恶性中胚叶混合瘤临床病理特征分析[J].广州医药,2025,56(02):160-165.DOI:10.20223/j.cnki.1000-8535.2025.02.003.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录